Hollsteen
← Everpure

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 FY2016: $173M · 10-Q 0001564590-16-020289 filed Jun 3, 2016Cash and equivalents · Q2 FY2016: $128M · 10-Q 0001628280-16-019406 filed Sep 6, 2016Cash and equivalents · Q3 FY2016: $573M · 10-Q 0001564590-15-011439 filed Dec 11, 2015Cash and equivalents · Q4 FY2016: $605M · 10-K 0001564590-16-015322 filed Mar 25, 2016Cash and equivalents · Q1 FY2017: $286M · 10-Q 0001564590-16-020289 filed Jun 3, 2016Cash and equivalents · Q2 FY2017: $206M · 10-Q 0001628280-16-019406 filed Sep 6, 2016Cash and equivalents · Q3 FY2017: $152M · 10-Q 0001628280-16-022007 filed Dec 13, 2016Cash and equivalents · Q4 FY2017: $184M · 10-K 0001628280-17-003034 filed Mar 29, 2017Cash and equivalents · Q1 FY2018: $169M · 10-Q 0001628280-17-006263 filed Jun 7, 2017Cash and equivalents · Q2 FY2018: $172M · 10-Q 0001628280-17-009061 filed Sep 5, 2017Cash and equivalents · Q3 FY2018: $182M · 10-Q 0001628280-17-012265 filed Dec 8, 2017Cash and equivalents · Q4 FY2018: $244M · 10-K 0001628280-18-003579 filed Mar 26, 2018Cash and equivalents · Q1 FY2019: $735M · 10-Q 0001628280-18-007756 filed Jun 8, 2018Cash and equivalents · Q2 FY2019: $370M · 10-Q 0001628280-18-011594 filed Sep 4, 2018Cash and equivalents · Q3 FY2019: $407M · 10-Q 0001628280-18-014872 filed Dec 6, 2018Cash and equivalents · Q4 FY2019: $448M · 10-K 0001628280-19-003437 filed Mar 26, 2019Cash and equivalents · Q1 FY2020: $287M · 10-Q 0001628280-19-007753 filed Jun 7, 2019Cash and equivalents · Q2 FY2020: $269M · 10-Q 0001628280-19-011331 filed Aug 30, 2019Cash and equivalents · Q3 FY2020: $304M · 10-Q 0001628280-19-014877 filed Dec 9, 2019Cash and equivalents · Q4 FY2020: $363M · 10-K 0001628280-20-004133 filed Mar 27, 2020Cash and equivalents · Q1 FY2021: $348M · 10-Q 0001628280-20-009289 filed Jun 11, 2020Cash and equivalents · Q2 FY2021: $356M · 10-Q 0001628280-20-013458 filed Sep 11, 2020Cash and equivalents · Q3 FY2021: $264M · 10-Q 0001628280-20-017299 filed Dec 9, 2020Cash and equivalents · Q4 FY2021: $337M · 10-K 0001628280-21-005538 filed Mar 25, 2021Cash and equivalents · Q1 FY2022: $301M · 10-Q 0001628280-21-011838 filed Jun 8, 2021Cash and equivalents · Q2 FY2022: $340M · 10-Q 0001628280-21-018247 filed Sep 8, 2021Cash and equivalents · Q3 FY2022: $405M · 10-Q 0001628280-21-024638 filed Dec 7, 2021Cash and equivalents · Q4 FY2022: $466M · 10-K 0001628280-22-008643 filed Apr 7, 2022Cash and equivalents · Q1 FY2023: $455M · 10-Q 0001628280-22-017288 filed Jun 16, 2022Cash and equivalents · Q2 FY2023: $653M · 10-Q 0001628280-22-024939 filed Sep 15, 2022Cash and equivalents · Q3 FY2023: $796M · 10-Q 0001628280-22-031956 filed Dec 15, 2022Cash and equivalents · Q4 FY2023: $581M · 10-K 0001628280-23-010275 filed Apr 3, 2023Cash and equivalents · Q1 FY2024: $378M · 10-Q 0001628280-23-022333 filed Jun 16, 2023Cash and equivalents · Q2 FY2024: $409M · 10-Q 0001628280-23-032228 filed Sep 14, 2023Cash and equivalents · Q3 FY2024: $529M · 10-Q 0001628280-23-041629 filed Dec 15, 2023Cash and equivalents · Q4 FY2024: $703M · 10-K 0001628280-24-013860 filed Apr 1, 2024Cash and equivalents · Q1 FY2025: $901M · 10-Q 0001628280-24-027955 filed Jun 13, 2024Cash and equivalents · Q2 FY2025: $965M · 10-Q 0001628280-24-040066 filed Sep 11, 2024Cash and equivalents · Q3 FY2025: $895M · 10-Q 0001628280-24-050852 filed Dec 12, 2024Cash and equivalents · Q4 FY2025: $724M · 10-K 0001628280-25-015044 filed Mar 27, 2025Cash and equivalents · Q1 FY2026: $739M · 10-Q 0001628280-25-030567 filed Jun 11, 2025Cash and equivalents · Q2 FY2026: $888M · 10-Q 0001474432-25-000046 filed Sep 10, 2025Cash and equivalents · Q3 FY2026: $853M · 10-Q 0001474432-25-000065 filed Dec 10, 2025Cash and equivalents · Q4 FY2026: $855M · 10-K 0001474432-26-000027 filed Mar 25, 2026Cash and equivalents · Q1 FY2027: $838M · 10-Q 0001474432-26-000061 filed Jun 5, 2026Cash and equivalents · Q2 FY2027: $386M · 10-Q 0001474432-26-000088 filed Sep 4, 2026363386173965Q1 FY2016Q2 FY2027Q4 FY2020
$MCash and equivalents · Q4 FY2019: $448M · 10-K 0001628280-19-003437 filed Mar 26, 2019Cash and equivalents · Q1 FY2020: $287M · 10-Q 0001628280-19-007753 filed Jun 7, 2019Cash and equivalents · Q2 FY2020: $269M · 10-Q 0001628280-19-011331 filed Aug 30, 2019Cash and equivalents · Q3 FY2020: $304M · 10-Q 0001628280-19-014877 filed Dec 9, 2019Cash and equivalents · Q4 FY2020: $363M · 10-K 0001628280-20-004133 filed Mar 27, 2020Cash and equivalents · Q1 FY2021: $348M · 10-Q 0001628280-20-009289 filed Jun 11, 2020Cash and equivalents · Q2 FY2021: $356M · 10-Q 0001628280-20-013458 filed Sep 11, 2020Cash and equivalents · Q3 FY2021: $264M · 10-Q 0001628280-20-017299 filed Dec 9, 2020363264448Q4 FY2019Q3 FY2021Q4 FY2020
Q4 FY2020
363$M
All values (46)
PeriodValue ($M)Status
Q2 FY2027386reported
Q1 FY2027838reported
Q4 FY2026855reported
Q3 FY2026853reported
Q2 FY2026888reported
Q1 FY2026739reported
Q4 FY2025724reported
Q3 FY2025895reported
Q2 FY2025965reported
Q1 FY2025901reported
Q4 FY2024703reported
Q3 FY2024529reported
Q2 FY2024409reported
Q1 FY2024378reported
Q4 FY2023581reported
Q3 FY2023796reported
Q2 FY2023653reported
Q1 FY2023455reported
Q4 FY2022466reported
Q3 FY2022405reported
Q2 FY2022340reported
Q1 FY2022301reported
Q4 FY2021337reported
Q3 FY2021264reported
Q2 FY2021356reported
Q1 FY2021348reported
Q4 FY2020363reported
Q3 FY2020304reported
Q2 FY2020269reported
Q1 FY2020287reported
Q4 FY2019448reported
Q3 FY2019407reported
Q2 FY2019370reported
Q1 FY2019735reported
Q4 FY2018244reported
Q3 FY2018182reported
Q2 FY2018172reported
Q1 FY2018169reported
Q4 FY2017184reported
Q3 FY2017152reported
Q2 FY2017206reported
Q1 FY2017286reported
Q4 FY2016605reported
Q3 FY2016573reported
Q2 FY2016128reported
Q1 FY2016173reported

CSV with all sources · Technical ID: cash

More metrics for Everpure

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$363M
Period
Q4 FY2020, ended Feb 2, 2020 · as of Feb 2, 2020 (balance as of date, not a sum)
Source
10-K, filed Mar 27, 2020 · 0001628280-20-004133
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$363MMar 27, 202010-K 0001628280-20-004133reported · confidence 1. · current